ADDEX THERAPEUTICS SA NAM.-AKTIE/ CH0029850754 /
9/11/2024 8:14:13 AM | Chg. 0.000 | Volume | Bid8:14:13 AM | Ask8:14:13 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.080EUR | 0.00% | - Turnover: - |
0.080Bid Size: - | 0.082Ask Size: - | 13.98 mill.EUR | - | - |
Assets
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 0.0000 | 0.0000 | 27.6000 | .1000 | .1000 | ||||||
Intangible Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 68.9000 | .1000 | .1000 | ||||||
Fixed Assets | 0.0000 | 0.0000 | 639.9000 | .7000 | .6000 | ||||||
Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 2.6000 | 41.7000 | 31.5000 | 18.7000 | 20.5000 | ||||||
Current Assets | 3.1000 | 42.2000 | 32.4000 | 19.5000 | 21.9000 | ||||||
Total Assets | 3.1000 | 42.2000 | 33 | 20.2000 | 22.5000 |
Liabilities
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1 | 2.1000 | 4.2000 | 2.5000 | 3.8000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 1.7000 | 2.9000 | 7.5000 | 5.6000 | 5.6000 | ||||||
Share Capital | 13.4000 | 28.6000 | 32.8000 | 32.8000 | 49.3000 | ||||||
Total Equity | 1.3000 | 39.2000 | 25.5000 | 14.6000 | 16.9000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 3.1000 | 42.2000 | 33 | 20.2000 | 22.5000 |
Income Statement
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | .5000 | 6.7000 | 2.9000 | 3.9000 | 3.1000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -3.2000 | -1.4000 | -14.6000 | -12.2000 | -15.5000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -3.3000 | -1.6000 | -14.8000 | -12.9000 | -15.4000 | ||||||
Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -3.3000 | -1.6000 | -14.8000 | -12.9000 | -15.4000 |
Per Share
Cash Flow
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -2.1000 | 1.8000 | -9.5000 | -12.2000 | -14.7000 | ||||||
Cash Flow from Investing Activities | 0.0000 | -.0600 | -.0400 | -.0600 | -.0300 | ||||||
Cash Flow from Financing | 3.4000 | 37.4000 | -.5000 | .0500 | 16.4000 | ||||||
Decrease / Increase in Cash | 1.2000 | 39.1000 | -10 | -12.2000 | 1.7000 | ||||||
Employees | 8 | 17 | 23 | 27 | 28 |